Skip to content

Schrodinger SDGR Restricted Cash

Restricted Cash at other companies

Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
$5.51M+79.2%
Absci Corporation logo
Absci CorporationABSI
$1.06M-93.4%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$25M0.0%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$1.34M-37.0%
Septerna, Inc. logo
Septerna, Inc.SEPN
$905K0.0%
Revvity logo
RevvityRVTY

Other financials

Income statement

See full
Revenue$58.6M-1.6%
Gross profit$29.5M-5.1%
Operating income-$48.8M+4.1%
Net income-$60.0M-0.4%
EPS (diluted)-$0.81+1.2%

Balance sheet

See full
Cash & equivalents$267.7M-20.7%
Total debt$107.0M-7.9%
Total equity$313.5M-16.1%
Total assets$634.2M-14.6%

Cash flow

See full
Operating cash flow-$14.8M-110%
CapEx$2.5M+321%
Free cash flow-$17.3M-112%

Valuation

See full
Market cap$1.15B-41.8%
Enterprise value$984.71M-44.4%
P/S4.5×-4.0×

Profitability

See full
Gross margin55.3%-7.3pp
Operating margin-64.7%-12.0pp
Net margin-68.5%
FCF margin9.6%+5.1pp

Returns & leverage

See full
Return on equity-45.7%
Debt / equity0.3×0.0×
Current ratio2.7×-0.7×

Where this comes from

Reported directly by Schrodinger in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.

The official record: Schrodinger’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Schrodinger's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Schrodinger's restricted cash?
Schrodinger (SDGR) reported restricted cash of $7.46M in Q1 2026.
How has Schrodinger's restricted cash changed year-over-year?
Schrodinger's restricted cash decreased by 36.6% year-over-year, from $11.76M to $7.46M.
What is the long-term trend for Schrodinger's restricted cash?
Over 5 years (2020 to 2025), Schrodinger's restricted cash has grown at a 68.9% compound annual growth rate (CAGR), from $500K to $6.87M.
What does restricted cash mean?
Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.